SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-13-121100
Filing Date
2013-03-22
Accepted
2013-03-22 09:07:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D d508077dsc13d.htm SC 13D 102692
2 EX-99.1 d508077dex991.htm EX-99.1 254110
  Complete submission text file 0001193125-13-121100.txt   358675
Mailing Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137 305-575-6015
Opko Health, Inc. (Filed by) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Subject) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86901 | Film No.: 13709329
SIC: 2834 Pharmaceutical Preparations